ArticleBiotechnology notes (Amsterdam, Netherlands)2022
2022 The 1st Western China symposium on the international frontier of synthetic biomanufacturing.
Article in Biotechnology notes (Amsterdam, Netherlands), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- 2022 The 1st Western China symposium on the international frontier of synthetic biomanufacturing.Biotechnology notes (Amsterdam, Netherlands) · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The 1st western China symposium on the international frontier of synthetic biomanufacturing was successfully held on July 8-10 in 2022. The conference is firstly launched by Professor Dan Wang in Chongqing University, and will be organized regularly every year by different universities in western China. The aim of this symposium is to show the cutting-edge knowledge of the synthetic biology developed in China and worldwide, provide a chance to meet international colleagues, and also to promote the academic and economic development of western China. Due to COVID-19, the 2022 symposium was masterfully delivered on the combination of online and offline operation, and the organisers must be commended for a really excellent and interactive meeting. The content of the conference involves two modules of synthetic biology and green biomanufacturing, covering eight aspects: synthetic biology, metabolic engineering, biological process engineering, industrial microbial breeding, biocatalysis and biotransformation, synthetic bio-materials, bio-medicine and biological separation engineering. More than 400 representatives were invited to gather together to exchange the latest research results and development trends in the field of synthetic biology and biomanufacturing. There was a significant focus on the younger scientists, both in terms of oral reports and posters. There were many excellent invited lectures and sessions beyond the remit of this short summary, including "Pharmaceutical manufacturing by biological methods" by Yuguo Zheng, Academician of the Chinese Academy of Engineering (CAE) Member of China, and a lecture "The third generation of biological manufacturing: preparing chemicals with CO
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.